What does Vaxfab Enterp. do?

Vaxfab Enterprises Ltd trades in fabrics and garments and operates in the micro-cap market. As of March 2025, it reported net sales of ₹3 Cr and a net profit of ₹2 Cr, with a market cap of ₹13 Cr.

Overview: <BR>Vaxfab Enterprises Ltd is engaged in the trading of fabrics and garments within the Trading & Distributors industry and operates in the micro-cap market segment.<BR><BR>History: <BR>The company was incorporated on 9th February 1983 in West Bengal and changed its name from Ellora Trading Limited to Vaxfab Enterprises Limited on 16th July 2022. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 3 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 2 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 13 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 13.00 <BR>Industry P/E: 30 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.02 <BR>Return on Equity: 4.50% <BR>Price to Book: 0.98 <BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Has Vaxfab Enterp. declared dividend?

No Dividend History Available

What is the technical trend for Vaxfab Enterp.?

As of May 16, 2025, Vaxfab Enterprises shows a strong bullish trend supported by positive MACD, Bollinger Bands, and moving averages across weekly and monthly time frames.

As of 16 May 2025, the technical trend for Vaxfab Enterp. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting a strong upward momentum. Bollinger Bands also indicate a bullish stance on both time frames. The daily moving averages confirm a bullish trend as well. The KST is bullish on the weekly and mildly bullish on the monthly, while Dow Theory shows a mildly bullish outlook in both time frames. Overall, the current technical stance is bullish with strong indicators supporting this trend.

Who are the peers of the Vaxfab Enterp.?

Vaxfab Enterp.'s peers include Shyam Telecom, New Light Appare, Dalmia Industria, Sumeru Industrie, Risa Internatio., IGC Industries, Diggi Multitrade, and Mitshi India. Vaxfab Enterp. leads in management quality, growth, and 1-year return at 71.60%, while IGC Industries has the lowest return at -89.50%.

Peers: The peers of Vaxfab Enterp. are Shyam Telecom, New Light Appare, Dalmia Industria, Sumeru Industrie, Risa Internatio., IGC Industries, Diggi Multitrade, and Mitshi India.<BR><BR>Quality Snapshot: Excellent management risk is observed at Vaxfab Enterp., while Below Average management risk is found at New Light Appare, Diggi Multitrade, and Mitshi India, and the rest do not qualify. Average growth is noted at Vaxfab Enterp., while Below Average growth is seen at New Light Appare, Diggi Multitrade, and Mitshi India, and the rest do not qualify. Good capital structure is present at Vaxfab Enterp., while Below Average capital structure is found at New Light Appare, Diggi Multitrade, and Mitshi India, and the rest do not qualify.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Vaxfab Enterp. at 71.60%, while the peer with the lowest is IGC Industries at -89.50%. Vaxfab Enterp.'s 1-year return significantly exceeds that of all its peers. Additionally, the six-month return is negative for IGC Industries, New Light Appare, and Mitshi India.

Who are in the management team of Vaxfab Enterp.?

As of March 2022, the management team of Vaxfab Enterprises includes Komal Jain (Company Secretary), Devi Singh (Managing Director), Premaram Patel (Independent Director), Kailash Gupta (Non-Executive Director), and Chinu Kalal (Independent Director).

As of March 2022, the management team of Vaxfab Enterprises includes the following individuals:<BR><BR>1. Komal Jain - Company Secretary<BR>2. Devi Singh - Managing Director<BR>3. Premaram Patel - Independent Director<BR>4. Kailash Gupta - Non Executive Director<BR>5. Chinu Kalal - Independent Director<BR><BR>These individuals play key roles in the governance and management of the company.

Who are the top shareholders of the Vaxfab Enterp.?

The top shareholders of Vaxfab Enterprises are primarily individual investors, holding 81.84% of the shares, with Varsha Vaibhav Patil as the largest public shareholder at 8.45%. There are no institutional investors or pledged promoter holdings.

The top shareholders of Vaxfab Enterprises include individual investors, who hold a significant 81.84% of the company's shares. Among public shareholders, Varsha Vaibhav Patil stands out with a holding of 8.45%. There are no institutional investors or mutual funds currently holding shares in the company, and there are no pledged promoter holdings.

How big is Vaxfab Enterp.?

As of 24th July, Vaxfab Enterprises Ltd has a market capitalization of 15.00 Cr, with recent net sales of 20.64 Cr and a net profit of 0.64 Cr. The company reported shareholder's funds of 16.47 Cr and total assets of 26.58 Cr for the annual period ending March 2023.

As of 24th July, Vaxfab Enterprises Ltd has a market capitalization of 15.00 Cr, categorized as a Micro Cap.<BR><BR>In the latest four quarters, Vaxfab Enterprises reported Net Sales of 20.64 Cr and a Net Profit of 0.64 Cr.<BR><BR>For the latest annual period ending in March 2023, the company had Shareholder's Funds amounting to 16.47 Cr and Total Assets of 26.58 Cr.

When is the next results date for Vaxfab Enterp.?

Vaxfab Enterp. is scheduled to declare its results on 14 August 2025.

Vaxfab Enterp. is scheduled to declare its results on 14 August 2025.

Are Vaxfab Enterp. latest results good or bad?

Vaxfab Enterprises reported strong financial results for June 2025, with net sales growing 1,392.44% year-on-year and a profit after tax of Rs 2.18 crore, a significant turnaround from a loss last year. However, the stock is rated 'Sell' by MarketsMOJO, indicating some caution among analysts despite the positive performance.

Vaxfab Enterprises has reported a strong financial performance for the quarter ending June 2025, showcasing significant growth in net sales and a turnaround in profitability. The company achieved net sales of Rs 17.76 crore, which is an impressive year-on-year growth of 1,392.44%. This indicates a robust demand for its products.<BR><BR>In terms of profitability, Vaxfab recorded a profit after tax (PAT) of Rs 2.18 crore for the latest six-month period, a notable improvement from a loss of Rs 0.59 crore in the previous year. This turnaround is particularly encouraging, as the company has already surpassed its PAT from the entire previous year within just half a year.<BR><BR>However, despite these positive indicators, the stock is currently rated as 'Sell' by MarketsMOJO, reflecting a decline in the company's score over the past three months. This mixed sentiment suggests that while the financial results are strong, there may be concerns regarding future performance or market conditions.<BR><BR>Overall, the latest results can be viewed as good in terms of growth and profitability, but the stock rating indicates caution among analysts.

How has been the historical performance of Vaxfab Enterp.?

Vaxfab Enterp. experienced significant growth from March 2022 to March 2023, with net sales rising to 16.75 Cr from 0.27 Cr, and a profit after tax of 0.33 Cr compared to 0.00 Cr the previous year. Total assets increased to 26.58 Cr from 3.15 Cr, indicating a strong financial improvement.

Answer:<BR>The historical performance of Vaxfab Enterp. shows significant growth from March 2022 to March 2023.<BR><BR>Breakdown:<BR>In March 2023, Vaxfab Enterp. reported net sales of 16.75 Cr, a substantial increase from 0.27 Cr in March 2022. Total operating income also rose to 16.75 Cr from 0.27 Cr, while total expenditure increased to 16.29 Cr from 0.36 Cr. The operating profit (PBDIT) improved to 0.46 Cr from a loss of 0.09 Cr, resulting in a profit before tax of 0.45 Cr compared to no profit in the previous year. Consequently, the profit after tax reached 0.33 Cr, up from 0.00 Cr. The consolidated net profit for March 2023 was 0.39 Cr, reflecting a notable improvement from the previous year's figure of 0.00 Cr. The company's equity capital increased to 8.40 Cr from 1.20 Cr, and total assets grew to 26.58 Cr from 3.15 Cr. Additionally, cash flow from operating activities was 1.00 Cr, with a net cash inflow of 4.00 Cr, indicating a positive cash position compared to the previous year.

Should I buy, sell or hold Vaxfab Enterp.?

Is Vaxfab Enterp. overvalued or undervalued?

As of November 17, 2025, Vaxfab Enterprises is considered undervalued with a PE ratio of 4.69, an EV to EBIT of 3.44, a ROCE of 61.79%, and a PEG ratio of 0.02, significantly outperforming peers and the Sensex, with a year-to-date return of 247.66%.

As of 17 November 2025, Vaxfab Enterprises has moved from a fair to a very attractive valuation grade. The company is currently considered undervalued, supported by a PE ratio of 4.69, an EV to EBIT of 3.44, and a remarkable ROCE of 61.79%. In comparison to peers, Vaxfab's valuation metrics stand out significantly; for instance, Elitecon International has a PE ratio of 294.38, while PTC India, another attractive peer, has a PE ratio of 7.56.<BR><BR>The company's strong performance is further underscored by its PEG ratio of 0.02, indicating substantial growth potential relative to its price. Despite a recent dip in stock price, Vaxfab has demonstrated impressive returns year-to-date at 247.66%, significantly outperforming the Sensex's 8.72% during the same period. Overall, the compelling valuation ratios and robust performance metrics suggest that Vaxfab Enterprises is indeed undervalued in the current market.

Which are the latest news on Vaxfab Enterp.?

Why is Vaxfab Enterp. falling/rising?

As of 03-Dec, Vaxfab Enterprises Ltd's stock price is stable at 36.00, with a slight weekly decline of 1.34% but a strong year-to-date increase of 251.56%. The stock shows positive investor sentiment and outperforms its sector, despite some short-term volatility.

As of 03-Dec, Vaxfab Enterprises Ltd's stock price is currently stable at 36.00, showing no change (0.00%). Despite this stability, the stock has experienced a slight decline of 1.34% over the past week, while the benchmark Sensex has only decreased by 0.59%. However, the stock has demonstrated strong performance year-to-date, with an impressive increase of 251.56%, significantly outperforming the Sensex's 8.92% gain during the same period.<BR><BR>Today's performance indicates that Vaxfab has outperformed its sector by 0.79%, suggesting positive investor sentiment. The stock is trading above its 50-day, 100-day, and 200-day moving averages, although it is below its 5-day and 20-day moving averages, which may indicate some short-term volatility. Additionally, there has been a rise in investor participation, with delivery volume increasing by 3.48% compared to the 5-day average, reflecting growing interest in the stock.<BR><BR>Overall, while the stock price remains unchanged today, the combination of strong year-to-date performance, increased investor participation, and outperformance against the sector suggests a generally positive outlook, despite recent short-term fluctuations.